Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. - Wikidata - wikimedia - TriplyDB

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

http://www.wikidata.org/entity/Q39337489

about

The Role of the Chemokine System in Tissue Response to Prosthetic By-products Leading to Periprosthetic Osteolysis and Aseptic Loosening.C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells.Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma.Quantitative proteomic analysis of murine white adipose tissue for peritoneal cancer metastasis.Immunoengineering with biomaterials for enhanced cancer immunotherapy.Natural Immunomodulators.Reverse of non-small cell lung cancer drug resistance induced by cancer associated fibroblasts via a paracrine pathway.Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors.Chemokines in homeostasis and diseases.Improving immune-vascular crosstalk for cancer immunotherapy.Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.Mast cells as sources of cytokines, chemokines, and growth factors.Novel adherent CD11b+ Gr-1+ tumor-infiltrating cells initiate an immunosuppressive tumor microenvironment.Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.A guide to chemokines and their receptors.Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer.Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.Gastric cancer increases transmigratory potential of peripheral blood monocytes by upregulation of β1- and β2-integrins.Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy.The novel long noncoding RNA u50535 promotes colorectal cancer growth and metastasis by regulating CCL20.CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)Role of mTOR Signaling in Tumor Microenvironment: An Overview Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma Divergent Expression Patterns and Function of Two cxcr4 Paralogs in Hermaphroditic Epinephelus coioides

P2860

Q41537137-9D0D006E-4423-4C80-BD8C-AC1894520F45 Q47119391-7999A576-5D77-420E-AF1D-9EA3A815D7B9 Q47121377-B903A81C-20B9-42E5-8A71-01EF53FEBA27 Q47164243-CC4E725F-286F-4F1E-8A52-9EF96BBE36A9 Q47241195-AD6982A0-E21A-4E23-8689-FB27335C1327 Q47732542-F4B8EFF1-D557-4328-B0D3-4AB2E354B814 Q48128829-D4131FE9-EC34-4C6F-8A74-712C77D7ABE8 Q48518636-9D2917CF-D3E7-4F1A-88E2-74DAE2AE11E2 Q49401353-A9D2041A-FDA1-4AB0-9217-2C82F35648D3 Q49634148-2D71EB90-5288-4B2F-BC62-D7147B6B9C1E Q50051034-8AB5775E-10C3-4FD2-9106-3C7670E67DAA Q50059071-2411CDDE-DF48-4E1B-AF5C-E91FF039A23F Q50068970-CE350010-66C1-4C21-A6DB-BF2877EE8E0F Q52655046-36E2B715-E84B-4E6E-8EFC-DF52E61AE513 Q53078069-6C981B07-A370-474E-A5F3-07472016DC0E Q54238056-E6B3CE54-29D0-43E1-88DE-4B1EF98AE319 Q54965295-DA9B065E-5052-4ACA-85D8-48DC627B40ED Q55019874-1E3EA811-DFBD-468C-B542-16DBEB809009 Q55021572-A8B5CF4E-6E17-4899-88D5-0FA031693FE4 Q55041791-8AD7E3FD-7F71-454D-9D99-1DACCB748177 Q55150815-5FEF4629-A489-4D49-B531-213041BD8182 Q55436369-EE08A622-C16F-49A8-8A6C-1FC972620532 Q55534075-C818B3FA-082D-4A89-9407-D8F77D7E9460 Q56892924-FFB8E1A2-17E0-44E1-82DC-43F56464ED98 Q56967396-AE5D3DFD-4ADD-4375-9065-C03238DE381A Q57082684-52AE2E97-9F86-4E86-BCBC-F157152F2A3F Q57138348-86966E72-9DEF-4896-9CEE-B7DB4AB3007D Q57160039-EC62354D-8B98-4A71-9B36-730EFB3CDBFA Q57492017-0DA5C340-7B6F-4458-8EA9-DE4D27EDA64F Q58567286-B7A77613-70FF-44D8-AF01-C69D85B80FC9 Q58696921-26D4A49C-A727-4754-B510-D73C4C1362FC Q58766017-812E0B36-9B72-4C08-894E-9D43EE60AAC7 Q58768316-EFA1B382-76A0-421D-B2AD-4625A74F0FE4 Q58773998-94DDA0C9-5803-4714-84FA-C1FA0E0448DA Q58796360-529E99D8-513A-4463-8CAA-745B06553445 Q59134127-33780422-CC34-4A8B-AF8E-6A6FA3F46909

P2860

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

http://www.wikidata.org/entity/Q39337489

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

@en

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

@nl

type

label

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

@en

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

@nl

prefLabel

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

@en

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

@nl

P1433

Q39337489-DDB6EC8B-BE40-4651-86E2-4E18BDD92E65

P1476

Q39337489-DFCA18CC-9DD4-447F-8F82-E0C659BEE99E

P2093

Q39337489-1D628334-CF49-4C85-AEFE-51F578A56418

Q39337489-2E7878A2-17E3-4AE0-8D39-4FA753C75FAF

Q39337489-78BAD717-2EDC-43F5-888D-9B8EE866E6EA

P2860

Q39337489-0015ECDA-8993-4C86-830E-52E2F64E4A54

Q39337489-0110C528-CA08-476B-AD66-8936EF612CC1

Q39337489-0140E6A3-0FE9-4E61-886D-4DA3C9CF7EAC

Q39337489-03B83707-3FAB-460E-97ED-2E7B0996F2DA

Q39337489-041C6D9A-E590-421F-8A3D-D8809C8EC14B

Q39337489-066D916B-78DB-4C28-AFBE-0912F523E42B

Q39337489-07105C82-8A6D-41CA-9238-F228564244F5

Q39337489-07F8FEEB-E7CD-4F42-9B1B-632B1F790E80

Q39337489-08B5CF7F-22EE-4AC8-9C9C-AB38D64E69C4

Q39337489-0C865CBA-2486-4835-BBBD-B28CEBBDC91B

P304

Q39337489-509BF5D0-EB05-4C38-B57F-8DD59C86C0EB

P31

Q39337489-22D6D86D-B8A6-4FB8-AA72-A81BF08062FF

P356

Q39337489-6AEC412D-01D7-4BCE-82DE-84BA1D2EE1C2

P433

Q39337489-C4BB84FD-1800-496B-980C-C206916E06BB

P478

Q39337489-A0D78A11-74D9-4AA9-A654-89B6015ADD76

P577

Q39337489-D32F8946-3B7B-4939-8B0E-F9B84178A9A9

P698

Q39337489-E8E09343-679A-41D7-92F1-D7F71CBFED93

P921

Q39337489-2648645B-DA4F-4E62-9CFB-24E0A803443C

P932

Q39337489-955472CB-2771-4EBE-8079-889CB2DFDAA9

P356

P1433

Nature Reviews Immunology

P1476

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

@en

P2093

Max S Wicha

http://www.w3.org/2001/XMLSchema#string

Nisha Nagarsheth

http://www.w3.org/2001/XMLSchema#string

Weiping Zou

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells

Involvement of chemokine receptors in breast cancer metastasis

CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3

The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression

The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes

Tumor-specific Th17-polarized cells eradicate large established melanoma

P304

559-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRI.2017.49

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28555670

http://www.w3.org/2001/XMLSchema#string

P921

P932

5731833

http://www.w3.org/2001/XMLSchema#string